European Commission logo
English English
CORDIS - EU research results

EIisa –a connected, affordable light solution for treating sleep apnea.

Project description

Non-invasive sleep apnea therapy

Sleep apnea is a sleep disorder characterized by intermittent periods of disrupted breathing that cause people to wake up during sleep. Sleep apnea is a major comorbidity of cardiovascular disease, and a significant risk factor for type 2 diabetes, stroke, coronary artery disease, congestive heart failure and atrial fibrillation, among other conditions. Gold standard therapy uses airway pressure devices causing discomfort to patients as it requires wearing a mask all night. Funded by the European Innovation Council, the SUNRISE Tx project proposes the first truly non-invasive, affordable, and readily accessible treatment to sleep apnea. The SUNRISE Tx system is a wearable device involving no nasal obstruction and using personalized muscle stimulation to prevent airways from collapsing during sleep.


Sunrise is a leading researcher and developer of solutions for diagnosis and treatment of sleep apnea. Our goal is to develop and commercialise Sunrise Tx, the first truly non-invasive, affordable and readily accessible solution to treat sleep apnea. This is to address the 80% treatment gap of sleep apnea sufferers who fail to access treatment due to high costs and long waiting times for diagnosis. Also, even within those diagnosed, at least 35% fail to comply with wearing a mask all night strapped tightly to the face, blowing air to clear airways for breathing due to the associated discomfort. In contrast Sunrise Tx is a wearable device involving no nasal obstruction. Sunrise Tx is set to improve treatment access, compliance, cost and accuracy.


Net EU contribution
€ 1 939 875,00
5101 NAMUR

See on map


The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Région wallonne Prov. Namur Arr. Namur
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Total cost
€ 2 771 250,00